Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01796072
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
FIN | A | 1ZVX | 0.71 | ||
LK1 | N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]- L-GLUTAMIC ACID | A | 2JFH | 0.8 | |
4MU | 7-hydroxy-4-methyl-2H-chromen-2- one | A,B | 3ETS | 0.71 | |
EIN | A | 1ZS0 | 0.71 | ||
AGG | TIROFIBAN | A,B | 2VDM | 0.74 | |
RWF | R-WARFARIN | A,B | 2BXD | 0.7 | |
667 | 6-OXO-8,9,10,11-TETRAHYDRO-7H-CYCLOHEPTA[C][1]BENZOPYRAN- 3-O-SULFAMATE | A | 1TTM | 0.77 | |
886 | N-({4'-[(4-isobutyrylphenoxy)methyl]biphenyl- 4-yl}sulfonyl)-D-valine | A,B,C,D | 2RJP | 0.79 | |
MZ9 | N-[(1S,2R)-1-BENZYL-2-HYDROXY-3- {[(4-METHOXYPHENYL)SULFONYL][(2S)- 2-METHYLBUTYL]AMINO}PROPYL]-4-OXOHEXANAMIDE | A,B | 2QI7 | 0.71 | |
C17 | 7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H- CHROMENE-4-CARBALDEHYDE | A,B | 2V60 | 0.7 | |
U03 | 4-HYDROXY-7-METHOXY-3-(1-PHENYL- PROPYL)-CHROMEN-2-ONE | A | 3UPJ | 0.76 | |
SWF | S-WARFARIN | A,B | 1OG5 | 0.7 | |
C18 | 7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]- 2H-CHROMEN-2-ONE | A,B | 2V61 | 0.74 | |
T33 | 3,3'-DEIODO-THYROXINE | A,B | 1THA | 0.72 | |
HBH | 2-[(8S,11S)-11-{(1R)-1-HYDROXY- 2-[ISOPENTYL(PHENYLSULFONYL)AMINO]ETHYL}- 6,9-DIOXO-2-OXA-7,10-DIAZABICYCLO[11.2.2]HEPTADECA- 1(15),13,16-TRIEN-8-YL]ACETAMIDE | A,B | 1Z1R | 0.7 | |
LK3 | N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}- D-GLUTAMIC ACID | A | 2UUO | 0.8 | |
LK4 | N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN- 2-YL}SULFONYL)-D-GLUTAMIC ACID | A | 2UUP | 0.76 | |
LK4 | N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN- 2-YL}SULFONYL)-D-GLUTAMIC ACID | A | 2VTE | 0.76 | |
LKM | N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN- 2-YL}SULFONYL)-D-GLUTAMIC ACID | A | 2VTD | 0.74 | |
HOM | 7-HYDROXY-4-METHYL-3-(2-HYDROXY- ETHYL)COUMARIN | C,D | 1CJF | 0.71 | |
LK2 | N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]- D-GLUTAMIC ACID | A | 2JFF | 0.8 | |
MUS | 4-METHYL-2-OXO-2H-CHROMEN-7-YL 5- (ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO- NON-2-ULOPYRANOSIDONIC ACID | A | 1S0J | 0.71 | |
MBS | A,B | 1HY7 | 0.78 | ||
WRR | 4-HYDROXY-3-[(1S,3R)-3-HYDROXY- 1-PHENYLBUTYL]-2H-CHROMEN-2-ONE | A | 1H9Z | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | X | 1Y0X | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A | 1HK1 | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | C,D | 1ICT | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A | 2RIW | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A,B | 2ROX | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A,B | 1IE4 | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | 1,2 | 1ETB | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | 1,2 | 1ETA | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A,B,C | 1SN0 | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A,B | 2CEO | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A,B | 1F86 | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A | 1HK4 | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A | 1HK2 | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A | 1HK5 | 0.71 | |
T44 | 3,5,3',5'-TETRAIODO-L-THYRONINE | A | 1HK3 | 0.71 | |
TBL | N-[(4-methoxyphenyl)sulfonyl]-D- alanine | A | 3EHY | 0.7 | |
FLU | 2-(6-HYDROXY-3-OXO-3H-XANTHEN-9- YL)-BENZOIC ACID | L | 1FLR | 0.7 | |
FLU | 2-(6-HYDROXY-3-OXO-3H-XANTHEN-9- YL)-BENZOIC ACID | A,B | 1N0S | 0.7 | |
FLU | 2-(6-HYDROXY-3-OXO-3H-XANTHEN-9- YL)-BENZOIC ACID | C,L | 1T66 | 0.7 | |
FLU | 2-(6-HYDROXY-3-OXO-3H-XANTHEN-9- YL)-BENZOIC ACID | A | 1X9Q | 0.7 | |
FLU | 2-(6-HYDROXY-3-OXO-3H-XANTHEN-9- YL)-BENZOIC ACID | A,D | 2NMV | 0.7 | |
WRS | 4-HYDROXY-3-[(1S,3S)-3-HYDROXY- 1-PHENYLBUTYL]-2H-CHROMEN-2-ONE | A | 1HA2 | 0.71 | |
HBB | N-{(2R)-2-HYDROXY-2-[(8S,11S)-8- ISOPROPYL-6,9-DIOXO-2-OXA-7,10- DIAZABICYCLO[11.2.2]HEPTADECA-1(15),13,16- TRIEN-11-YL]ETHYL}-N-ISOPENTYLBENZENESULFONAMIDE | A,B | 1Z1H | 0.72 |